Search
Research
Skin Care Assessment in Broome and Port Hedland (SCAB Heal) projectSkin disease has several serious complications including heart and kidney disease.
News & Events
The Kids Research Institute Australia researchers share in TPCHRF fundingSix The Kids Research Institute Australia researchers are among those who have received grant funding from the Telethon-Perth Children’s Hospital Research Fund (TPCHRF).
News & Events
The Kids Research Institute Australia to lead international research team in tackling acute rheumatic feverAn international research team led by The Kids Research Institute Australia has been awarded a $5 million Synergy Grant by the NHMRC.
News & Events
The Kids researchers named as finalists in 2020 Premier’s Science AwardsTwo The Kids Research Institute Australia researchers have been named as finalists in the 2020 Western Australian Premier’s Science Awards.
Research
Play Active Program – physical activity policy and training for Early Childhood Education and CarePlay Active is a national, low-cost, evidence-based program to boost energetic play in early childhood education and care. It offers free professional development for educators.
Research
CFC ReportThe Tasmanian Government has made a significant commitment in recent years to ensure children have the best possible start in life.
Research
Positive End-Expiratory Pressure Levels during Resuscitation of Preterm Infants at Birth: The POLAR TrialInvestigators: Andrew Gill External collaborators: Assoc Prof David Tingay (Murdoch Children's Research Institute) The POLAR trial is an MRFF-funded
Research
Environmental and lifestyle changes in the antenatal population over the past three decades: A comparative study utilising Raine Study and Joondalup Health Campus birth cohort dataInvestigators: Catherine Nguyen, Lauren Fisher, Lauren Nguyen This study investigated changes in prevalence of environmental and lifestyle risk
A picture of early childhood services in Tasmania from birth to age five
Research
Setonix Pharmaceuticals: Enhancing immuno-oncology with small molecule drugsSetonix Pharmaceuticals aim to develop orally available immunotherapy drugs that are optimally effective with minimal side effects, improving outcomes for cancer patients.